DrugApr 8, 2026
LEADER ARTIFICIAL TEARS 15 ML Artificial Tears Sterile Lubricant Eye Drops recall — FDA D-0416-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
Recall history in this database
Classification mix: Class II: 11, Class III: 4.
DrugApr 8, 2026
LEADER ULTRA LUBRICATING EYE DROPS Ultra Lubricating Eye Drops recall — FDA D-0412-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
GOODSENSE EYE DROPS ORIGINAL FORMULA Sterile Eye Drops ORIGINAL FORMULA recall — FDA D-0413-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
ARTIFICIAL TEARS Dry Eye Relief Eye Drops recall — FDA D-0411-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
LEADER EYE DROPS REDNESS RELIEF Sterile EYE DROPS REDNESS LUBRICANT recall — FDA D-0414-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
QUALITY CHOICE MOISTURIZING RELIEF EYE DROPS EYE DROPS Advanced Relief recall — FDA D-0410-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
QUALITY CHOICE EYE DROPS IRRITATION RELIEF Sterile EYE DROPS AC recall — FDA D-0409-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
K.C. Pharmaceuticals STERILE EYE DROPS SOOTHING TEARS recall — FDA D-0415-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugJul 19, 2023
EQUATE EYE DROPS DRY EYE RELIEF Dry Eye Relief Lubricant Eye Drops recall — FDA D-0898-2023
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc.
DrugJul 19, 2023
SUNMARK EYE DROPS ORIGINAL FORMULA Original Eye Drops recall — FDA D-0897-2023
CGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc.
DrugDec 31, 2014
K C Pharmaceuticals Eye Drops A.C recall — FDA D-0321-2015
CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.
Class IIIFDA: TerminatedK C Pharmaceuticals Inc.
DrugDec 31, 2014
SUNMARK EYE DROPS ADVANCED MOISTURIZER/LUBRICANT Eye Drops Advanced Relief recall — FDA D-0323-2015
CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.
Class IIIFDA: TerminatedK C Pharmaceuticals Inc.
DrugDec 31, 2014
SUNMARK EYE DROPS ORIGINAL FORMULA Eye Drops recall — FDA D-0320-2015
CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.
Class IIIFDA: TerminatedK C Pharmaceuticals Inc.
DrugDec 31, 2014
K C Pharmaceuticals Eye Drops Industrial Strength recall — FDA D-0322-2015
CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.
Class IIIFDA: TerminatedK C Pharmaceuticals Inc.
DrugMar 20, 2013
K C Pharmaceuticals Eye Drops advanced relief recall — FDA D-192-2013
Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG…
Class IIFDA: TerminatedK C Pharmaceuticals Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies K.C. Pharmaceuticals, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.